Fraunhofer-Institut für Zelltherapie und Immunologie IZIEntzündungs- und Tumormodelle
- Zhupanyn P, Ewe A, Büch T, Malek A, Rademacher P, Müller C, Reinert A, Jaimes Y, Aigner A. Extracellular vesicle (ECV)-modified polyethylenimine (PEI) complexes for enhanced siRNA delivery in vitro and in vivo. Journal of controlled release 319 (2020) Seite 63-76. dx.doi.org/10.1016/j.jconrel.2019.12.032
- Walcher L, Müller C, Hilger N, Kretschmer A, Stahl L, Wigge S, Rengelshausen J, Müller AM, Fricke S. Effect of combined sublethal X-ray irradiation ancyclosporine a treatment in NOD scid gamma (NSG) mice. Experimental animals 68 (2019), 1, Seite 1-11, dx.doi.org/10.1538/expanim.18-0056
- Hilger N, Glaser J, Müller C, Halbich C, Müller A, Schwertassek U, Lehmann J, Ruschpler P, Lange F, Boldt A, Stahl L, Sack U, Oelkrug C, Emmrich F, Fricke S. Attenuation of graft-versus-host-disease in NOD scid IL-2Rγ(-/-) (NSG) mice by ex vivo modulation of human CD4(+) T cells. Cytometry A. 2016, 89(9), S. 803-815. Epub 2016 Aug 25. doi: 10.1002/cyto.a.22930.
- Diehl R, Ferrara F, Müller C, Dreyer AY, McLeod DD, Fricke S, Boltze J. Immunosuppression for in vivo research: state-of-the-art protocols and experimental approaches. Cellular and Molecular Immunology 2016, 13, S. 1–34. Epub 2016 Oct 10. doi: 10.1038/cmi.2016.39
- Wege AK, Schmidt M, Ueberham E, Ponnath M, Ortmann O, Brockhoff G, Lehmann J. Co-transplantation of human hematopoietic stem cells and human breast cancer cells in NSG mice: a novel approach to generate tumor cell specific human antibodies. MAbs. Jul-Aug 2014;6(4):968-77. doi: 10.4161/mabs.29111. Epub 2014 May 8.